TY - JOUR
T1 - Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization
AU - Levin, Iris
AU - Cohen, Jacob
AU - Supino-Rosin, Lia
AU - Yoshimura, Akihiko
AU - Watowich, Stephanie S.
AU - Neumann, Drorit
N1 - Funding Information:
We thank Dr. J. Ihle for kindly providing the cDNA of PB (Δ281–300), Ms. Hideko Ohgusu for the preparation of 1–267 EPO-R and Profs. Yoav Henis and Ronit Sagi-Eisenberg for critically reviewing the manuscript. This work was supported by a grant from the Ministry of Science, Israel, within the corporation program with the Science and Technology of Japan, by grants from the Israel Science Foundation administered by the Israel Academy of Sciences and Humanities, the Israel Cancer Research Fund (RCDA), and the Israeli Ministry of Science and Technology to D.N. and by a grant-in-aid from the American Heart Association, Texas Affiliate, Inc. (#96G-1616) to S.S.W. This work was performed in partial fulfillment of the requirements of an M.Sc. degree for I.L. and of Ph.D. degrees for J.C. and L.S.-R.
PY - 1998/5/8
Y1 - 1998/5/8
N2 - Erythropoietin (EPO) promotes the viability, proliferation and differentiation of mammalian erythroid progenitor cells via its specific cell surface receptor. The EPO receptor (EPO-R) is a member of the cytokine receptor superfamily and is comprised of one identified subunit which homodimerizes upon ligand binding. To study the role of the intracellular domain of the EPO-R in the endocytosis of EPO, we compared the rate and extent of 125I-EPO endocytosis by mild type (wt) EPO-R and five cytoplasmically truncated EPO-Rs: 1-251 EPO-R, 1-257 EPO-R, 1-267 EPO-R, 1-276 EPO-R and 1-306 EPO-R which contain 4, 10, 20, 29 or 59 amino acids of the cytoplasmic domain, respectively. We also studied an EPO-R mutant (PB) which lacks amino acid residues 281-300 of the cytoplasmic domain. The experiments were conducted in COS 7 cells transfected with the EPO-R cDNAs and in Ba/F3 cells stably expressing the wt EPO-R, 1-251 or 1-257 EPO-R. Cells expressing wt EPO-R, PB EPO-R (Δ281-300), 1-276 EPO-R or 1-306 EPO-R internalized approximately 50% of 125I-EPO bound to the cell surface, while cells expressing 1-251, 1-257 or 1-267 EPO-R internalized only 25% of the bound 1251-EPO. The steady-state expression levels of these latter receptors on the cell surface were typically 2-5-fold higher than wt EPO-R. Our data indicate that amino acid residues 267-276 (FEGLFTTHK) of the EPO-R cytoplasmic domain may have a role in receptor internalization. Metabolic labeling experiments suggest that in transiently transfected COS 7 cells most of the wt EPO-R and 1-257 EPO-Rs do not exit the ER and may be degraded there. The half-life or both receptors was essentially similar and was in the range of 1 h. In Ba/F3 cells the mature Golgi processed 1-257 EPO-R was more stable than the corresponding form of the wt EPO-R, possibly contributing to its higher cell surface expression.
AB - Erythropoietin (EPO) promotes the viability, proliferation and differentiation of mammalian erythroid progenitor cells via its specific cell surface receptor. The EPO receptor (EPO-R) is a member of the cytokine receptor superfamily and is comprised of one identified subunit which homodimerizes upon ligand binding. To study the role of the intracellular domain of the EPO-R in the endocytosis of EPO, we compared the rate and extent of 125I-EPO endocytosis by mild type (wt) EPO-R and five cytoplasmically truncated EPO-Rs: 1-251 EPO-R, 1-257 EPO-R, 1-267 EPO-R, 1-276 EPO-R and 1-306 EPO-R which contain 4, 10, 20, 29 or 59 amino acids of the cytoplasmic domain, respectively. We also studied an EPO-R mutant (PB) which lacks amino acid residues 281-300 of the cytoplasmic domain. The experiments were conducted in COS 7 cells transfected with the EPO-R cDNAs and in Ba/F3 cells stably expressing the wt EPO-R, 1-251 or 1-257 EPO-R. Cells expressing wt EPO-R, PB EPO-R (Δ281-300), 1-276 EPO-R or 1-306 EPO-R internalized approximately 50% of 125I-EPO bound to the cell surface, while cells expressing 1-251, 1-257 or 1-267 EPO-R internalized only 25% of the bound 1251-EPO. The steady-state expression levels of these latter receptors on the cell surface were typically 2-5-fold higher than wt EPO-R. Our data indicate that amino acid residues 267-276 (FEGLFTTHK) of the EPO-R cytoplasmic domain may have a role in receptor internalization. Metabolic labeling experiments suggest that in transiently transfected COS 7 cells most of the wt EPO-R and 1-257 EPO-Rs do not exit the ER and may be degraded there. The half-life or both receptors was essentially similar and was in the range of 1 h. In Ba/F3 cells the mature Golgi processed 1-257 EPO-R was more stable than the corresponding form of the wt EPO-R, possibly contributing to its higher cell surface expression.
KW - Endocytosis
KW - Erythropoietin
KW - Erythropoietin receptor
UR - http://www.scopus.com/inward/record.url?scp=0032496370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032496370&partnerID=8YFLogxK
U2 - 10.1016/S0014-5793(98)00414-1
DO - 10.1016/S0014-5793(98)00414-1
M3 - Article
C2 - 9607304
AN - SCOPUS:0032496370
SN - 0014-5793
VL - 427
SP - 164
EP - 170
JO - FEBS Letters
JF - FEBS Letters
IS - 2
ER -